James M. Gower
2006
In 2006, James M. Gower earned a total compensation of $2.5M as Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $150,150 |
|---|---|
| Option Awards | $1,891,862 |
| Salary | $455,000 |
| Other | $2,315 |
| Total | $2,499,327 |
Gower received $1.9M in option awards, accounting for 76% of the total pay in 2006.
Gower also received $150.2K in non-equity incentive plan, $455K in salary and $2.3K in other compensation.
Rankings
In 2006, James M. Gower's compensation ranked 1,374th out of 7,022 executives tracked by ExecPay. In other words, Gower earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,374 out of 7,022 | 80th |
Division Manufacturing | 427 out of 2,413 | 82nd |
Major group Chemicals And Allied Products | 72 out of 673 | 89th |
Industry group Drugs | 38 out of 518 | 93rd |
Industry Pharmaceutical Preparations | 32 out of 355 | 91st |
Source: SEC filing on April 15, 2009.
Gower's colleagues
We found five more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2006.
2006
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2006
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2006
Elliott Grossbard
Rigel Pharmaceuticals
Chief Medical Officer
2006
James Welch
Rigel Pharmaceuticals
Chief Financial Officer
2006
Ryan Maynard
Rigel Pharmaceuticals